TY - JOUR T1 - Hyperchloraemic metabolic acidosis JF - Emergency Medicine Journal JO - Emerg Med J SP - 613 LP - 613 DO - 10.1136/emj.2008.059923 VL - 25 IS - 9 AU - F S Y Fan AU - K M Chow AU - C C Szeto AU - P K T Li Y1 - 2008/09/01 UR - http://emj.bmj.com/content/25/9/613.abstract N2 - Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone. ER -